Crackdown On Substandard Ayurvedic Medicines

THIRUVANANTHAPURAM: Various batches of ayurvedic medicines of Rajasthan Herbal International Pvt Ltd have been found to be of substandard quality during quality tests conducted at the drug testing laboratories of the State Drugs Controller’s Department. Following this, the Ayurvedic Drugs Control Department banned the distribution and sale of these medicines.

 

Traders and hospitals holding stock of drugs should return the same to the distributor and inform the District Ayurvedic Drugs Inspectors concerned, the officials said. Name and batch number of medicines are: Pain Niwaran Churna (PNF21057), Dr Relaxi Capsule (DRG21019), Pain Niwaran Churna (PNK21089), Mood on Forever (MCE21003), Dr Relaxi Capsule (DRK21030), Dr Relaxi Oil (DOD21004), Dama Buti Churna (DBH21017), Asthalex Capsule (ALK21004).

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert